Literature DB >> 33665594

Overlapping measures or constructs? An empirical study of the overlap between self-control, psychopathy, Machiavellianism and narcissism.

Matt DeLisi1, Pedro Pechorro2, João Maroco3, Mário Simões4.   

Abstract

Overlap between self-control and dark triad traits (i.e., psychopathy, Machiavellianism, and narcissism) is potentially problematic for efforts to distinguish dimensions associated with elevated risk for antisociality and crime. The aim of the present study is to examine the potential overlap between self-control and psychopathy, Machiavellianism, and narcissism, with a focus on the Brief Self-Control Scale (BSCS) and the Dirty Dozen Dark Triad scale (DD). The sample consisted of 567 youth (M = 15.91 years, SD = 0.99 years, age range = 14-18 years) from Portugal. Exploratory and confirmatory factor analysis results from the pooled set of items of the BSCS and the DD measures revealed that both are valid and reliable measures of their respective constructs. However, consistent with previous research, the narcissism facet of the DD emerged as an independent factor. Our findings suggest that if such an eventual overlap is detected, it would be a question of problematic measures, not constructs.
© 2021 The Author(s).

Entities:  

Keywords:  Machiavellianism; Narcissism; Overlap; Psychopathy; Self-control

Year:  2021        PMID: 33665594      PMCID: PMC7903057          DOI: 10.1016/j.fsisyn.2021.100141

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 2589-871X            Impact factor:   2.395


  15 in total

1.  High self-control predicts good adjustment, less pathology, better grades, and interpersonal success.

Authors:  June P Tangney; Roy F Baumeister; Angie Luzio Boone
Journal:  J Pers       Date:  2004-04

2.  A large-scale meta-analysis relating the hare measures of psychopathy to antisocial conduct.

Authors:  Anne-Marie R Leistico; Randall T Salekin; Jamie DeCoster; Richard Rogers
Journal:  Law Hum Behav       Date:  2007-07-13

3.  An examination of the Dirty Dozen measure of psychopathy: a cautionary tale about the costs of brief measures.

Authors:  Joshua D Miller; Lauren R Few; L Alana Seibert; Ashley Watts; Amos Zeichner; Donald R Lynam
Journal:  Psychol Assess       Date:  2012-05-21

4.  Taking stock of self-control: a meta-analysis of how trait self-control relates to a wide range of behaviors.

Authors:  Denise T D de Ridder; Gerty Lensvelt-Mulders; Catrin Finkenauer; F Marijn Stok; Roy F Baumeister
Journal:  Pers Soc Psychol Rev       Date:  2011-08-30

5.  Differences among dark triad components: A meta-analytic investigation.

Authors:  Colin E Vize; Donald R Lynam; Katherine L Collison; Joshua D Miller
Journal:  Personal Disord       Date:  2016-10-13

6.  The dirty dozen: a concise measure of the dark triad.

Authors:  Peter K Jonason; Gregory D Webster
Journal:  Psychol Assess       Date:  2010-06

Review 7.  The I3 Model: a metatheoretical framework for understanding aggression.

Authors:  Eli J Finkel; Andrew N Hall
Journal:  Curr Opin Psychol       Date:  2017-04-18

8.  Which features of psychopathy and impulsivity matter most for prison violence? New evidence among female prisoners.

Authors:  Nicholas D Thomson; Jasmin Vassileva; Kent A Kiehl; Dennis Reidy; Michel Aboutanos; Robyn McDougle; Matt DeLisi
Journal:  Int J Law Psychiatry       Date:  2019-01-24

9.  Childhood forecasting of a small segment of the population with large economic burden.

Authors:  Avshalom Caspi; Renate M Houts; Daniel W Belsky; Honalee Harrington; Sean Hogan; Sandhya Ramrakha; Richie Poulton; Terrie E Moffitt
Journal:  Nat Hum Behav       Date:  2016-12-12

10.  A gradient of childhood self-control predicts health, wealth, and public safety.

Authors:  Terrie E Moffitt; Louise Arseneault; Daniel Belsky; Nigel Dickson; Robert J Hancox; Honalee Harrington; Renate Houts; Richie Poulton; Brent W Roberts; Stephen Ross; Malcolm R Sears; W Murray Thomson; Avshalom Caspi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.